Under a new collaboration unveiled Wednesday, Lyndra is bringing Thermo Fisher on deck to tackle commercial manufacturing and global clinical research services for the company’s roster of long-acting drug candidates. More: Lyndra taps Thermo Fisher to help with research, commercial
read moreAmong the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda said it’s laser-focused on six pipeline assets that could each reel in blockbuster-level sales down the line. More: JPM25: Takeda spotlights
read more
Funds to accelerate commercialisation and clinical trials of diagnostic tests More: Owlstone Medical announces million USD first close in Series E financing round Source: News
read more
Promising results from mouse study lead to expanded trials More: Oxford Drug Design achieves in vivo validation for novel cancer treatment Source: News
read moreOne day after Samsung Biologics revealed in a regulatory filing that it had signed its largest contract in company history, the CDMO giant said it’s considering the construction of a sixth manufacturing plant. More: JPM25: Amid Samsung Bio's rapid expansion,
read moreEven after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more companies are set to take the stage on Wednesday. More: JPM25, Day 3: AbbVie's 'clear runway to growth' allows it
read more© 1994 - 2026 B.M. Pharmaceuticals